Literature DB >> 12502874

Simian virus 40 sequences in human lymphoblastoid B-cell lines.

Riccardo Dolcetti1, Fernanda Martini, Michele Quaia, Annunziata Gloghini, Beatrice Vignocchi, Roberta Cariati, Marcella Martinelli, Antonino Carbone, Mauro Boiocchi, Mauro Tognon.   

Abstract

Human Epstein-Barr virus-immortalized lymphoblastoid B-cell lines tested positive by PCR for simian virus 40 (SV40) DNA (22 of 42 cell lines, 52.3%). B lymphocytes or tissues from which B-cell lines derived were also SV40 positive. In situ hybridization showed that SV40 DNA was present in the nucleus of a small fraction (1/250) of cells. SV40 T-antigen mRNA was detected by reverse transcription-PCR. Lymphoblastoid B-cell lines (n = 4) infected with SV40 remained SV40 positive for 4 to 6 months. SV40-positive B-cell lines were more tumorigenic in SCID mice than were SV40-negative cell lines (4 of 5 [80%] SV40-positive cell lines versus 2 of 4 [50%] SV40-negative cell lines). These results suggest that SV40 may play a role in the early phases of human lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502874      PMCID: PMC140833          DOI: 10.1128/jvi.77.2.1595-1597.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease.

Authors:  R Dolcetti; M Quaia; A Gloghini; V De Re; P Zancai; R Cariati; L Babuin; A M Cilia; S Rizzo; A Carbone; M Boiocchi
Journal:  Int J Cancer       Date:  1999-01-18       Impact factor: 7.396

Review 2.  Association of SV40 with human tumours.

Authors:  B Jasani; A Cristaudo; S A Emri; A F Gazdar; A Gibbs; B Krynska; C Miller; L Mutti; C Radu; M Tognon; A Procopio
Journal:  Semin Cancer Biol       Date:  2001-02       Impact factor: 15.707

3.  SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma.

Authors:  P Cacciotti; R Libener; P Betta; F Martini; C Porta; A Procopio; L Strizzi; L Penengo; M Tognon; L Mutti; G Gaudino
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

4.  Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors.

Authors:  Fernanda Martini; Lorena Lazzarin; Laura Iaccheri; Beatrice Vignocchi; Gaetano Finocchiaro; Ivana Magnani; Massimo Serra; Katia Scotlandi; Giuseppe Barbanti-Brodano; Mauro Tognon
Journal:  Cancer       Date:  2002-02-15       Impact factor: 6.860

5.  Effect of human cytomegalovirus on replication of SV40 origin and the expression of T antigen.

Authors:  G S Pari; S C St Jeor
Journal:  Virology       Date:  1990-08       Impact factor: 3.616

6.  Simian virus 40 is present in human lymphomas and normal blood.

Authors:  H David; S Mendoza; T Konishi; C W Miller
Journal:  Cancer Lett       Date:  2001-01-10       Impact factor: 8.679

7.  Presence of simian virus 40 DNA sequences in human lymphomas.

Authors:  Narayan Shivapurkar; Kenichi Harada; Jyotsna Reddy; Richard H Scheuermann; Yin Xu; Robert W McKenna; Sara Milchgrub; Steven H Kroft; Ziding Feng; Adi F Gazdar
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

8.  Association between simian virus 40 and non-Hodgkin lymphoma.

Authors:  Regis A Vilchez; Charles R Madden; Claudia A Kozinetz; Steven J Halvorson; Zoe S White; Jeffrey L Jorgensen; Chris J Finch; Janet S Butel
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

9.  Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDS-related systemic non-Hodgkin lymphoma.

Authors:  Regis A Vilchez; John A Lednicky; Steven J Halvorson; Zoe S White; Claudia A Kozinetz; Janet S Butel
Journal:  J Acquir Immune Defic Syndr       Date:  2002-02-01       Impact factor: 3.731

10.  High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients.

Authors:  H Yamamoto; T Nakayama; H Murakami; T Hosaka; T Nakamata; T Tsuboyama; M Oka; T Nakamura; J Toguchida
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  7 in total

Review 1.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

2.  Inability of simian virus 40 to establish productive infection of lymphoblastic cell lines.

Authors:  Sophie Shaikh; Christine Skoczylas; Richard Longnecker; Kathleen Rundell
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

3.  Reactivation of infectious simian virus 40 from normal human tissues.

Authors:  Giuseppe Barbanti-Brodano; Fernanda Martini; Alfredo Corallini; Lorena Lazzarin; Cecilia Trabanelli; Beatrice Vignocchi; Nilla Calza; Laura Iaccheri; Cristina Morelli; Mauro Tognon
Journal:  J Neurovirol       Date:  2004-06       Impact factor: 2.643

Review 4.  Simian virus 40 and its association with human lymphomas.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

Review 5.  Association Between Simian Virus 40 and Human Tumors.

Authors:  John Charles Rotondo; Elisa Mazzoni; Ilaria Bononi; Mauro Tognon; Fernanda Martini
Journal:  Front Oncol       Date:  2019-07-25       Impact factor: 6.244

6.  Serological evidence of an early seroconversion to Simian virus 40 in healthy children and adolescents.

Authors:  Angelo Taronna; Elisa Mazzoni; Alfredo Corallini; Ilaria Bononi; Silvia Pietrobon; Giovanni Guerra; Caterina Palmonari; Caterina Borgna-Pignatti; Manola Comar; Massimo Bovenzi; Ferruccio Casali; Roberto Marci; Giovanni Rezza; Giuseppe Barbanti-Brodano; Mauro Tognon; Fernanda Martini
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

7.  Simian virus 40 in humans.

Authors:  Fernanda Martini; Alfredo Corallini; Veronica Balatti; Silvia Sabbioni; Cecilia Pancaldi; Mauro Tognon
Journal:  Infect Agent Cancer       Date:  2007-07-09       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.